Back to Clinical Trials Overview

Your search for "Blood Disorders" returned 10 results:

A Phase II , Single-Center, Open Label study of Oral Panobinostat (LBH589) when administered in combination with Lenalidomide and weekly Dexamethasone in patients with multiple myeloma
Principal Investigator(s): Ajai Chari

Intensified Methotrexate,Nelarabine & Augmented BFM Ther (AALL0434)
Principal Investigator(s): Birte Wistinghausen

Nutritional vitamin D in patients with sickle cell disease
Principal Investigator(s): Jena Simon

A Multi-center, double-blind, randomized study evaluating de novo weekly and once every 2 week darbepoetin alfa dosing for the correction of anemia in pediatric subjects with chronic kidney disease recieving and not receiving dialysis
Principal Investigator(s): Benchimol, Corinne

Clarification of Optimal Anticoagulation through Genetics (COAG)
Principal Investigator(s): Desnick, Robert J.

An Oservational, ex vivo Clinical Trial of Intrinsic Pathway Antagonists in Patients Undergoing Warfarin Therapy
Principal Investigator(s): Moskowitz, Alan

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,
Principal Investigator(s): Gelijns, Gelijns

MPD Research Consortium/CORE C [00600]
Principal Investigator(s): Najfeld, Vesna

Hemophagocytic Lymphohistiocystosis Study Group
Principal Investigator(s): Del Toro, Gustavo

A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome
Principal Investigator(s): Paula J. Busse